Related Experiment Video
Updated: Jun 10, 2026
07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
[Metachromatic leucodystrophy. Clinical, biological, and therapeutic aspects]
Ilhem Barboura1, Salima Ferchichi, Azza Dandana
1Laboratoire de biochimie, CHU Farhat Hached, Sousse, Tunisia. ilhembarboura@yahoo.fr
Annales De Biologie Clinique
|July 24, 2010
Summary
Metachromatic leukodystrophy (MLD) is a lysosomal storage disease due to arylsulfatase A deficiency. Gene analysis offers a reliable diagnosis, unlike enzyme activity, aiding in managing this rare neurological disorder.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Context:
- Metachromatic leukodystrophy (MLD) is a rare lysosomal storage disease.
- It results from arylsulfatase A (ARSA) deficiency, crucial for sphingolipid metabolism.
- Pathological sulfatide accumulation in the nervous system causes severe neurological and mental deficits.
Purpose:
- To investigate the role of ARSA deficiency in MLD.
- To explore diagnostic approaches for MLD.
- To review current therapeutic strategies for MLD.
Summary:
- MLD is caused by deficient ARSA activity, leading to toxic sulfatide buildup in the nervous system.
- While ARSA enzyme activity is low in MLD patients, it doesn't predict disease severity.
- Analyzing the ARSA gene provides a more reliable diagnosis, distinguishing MLD from pseudo-deficiency.
Impact:
- Highlights the importance of genetic analysis for accurate MLD diagnosis.
- Emphasizes the limitations of enzyme activity assays in predicting clinical outcomes.
- Underscores the need for effective therapeutic interventions to manage MLD progression and reduce patient morbidity.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...